Clinical Trial Update: IRB-HSR# 13957: IV Lidocaine for Patients Undergoing Primary Breast Cancer Surgery: [Phase 2]

View source ↗

Summary

Phase 2 clinical trial completed evaluating IV lidocaine for patients undergoing primary breast cancer surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Lidocaine (Lidocaine)

Snippet

Sponsor: University of Virginia | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED